| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 05/10/2007 | CA2628210A1 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives |
| 05/10/2007 | CA2627502A1 Process for production of benzyloxypyrrolidine derivative, and process for production of hydrochloride salt powder of optically active benzyloxypyrrolidine derivative |
| 05/09/2007 | EP1783113A2 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| 05/09/2007 | EP1782804A1 Medicinal composition as immunosuppressant |
| 05/09/2007 | EP1781641A1 Pyrrolo-naphthyl acids as pai-1 inhibitors |
| 05/09/2007 | EP1781636A1 Pyrrole derivatives, their preparation and their therapeutic use |
| 05/09/2007 | EP1781607A2 Pyrrolidine derivatives as muscarinic receptor antagonists |
| 05/09/2007 | EP1254907B1 Pyrrolopyridazine compound |
| 05/09/2007 | EP1238970B9 Cycloamine ccr5 receptor antagonists |
| 05/09/2007 | EP0711177B1 Improvements relating to the preparation of prodrugs |
| 05/09/2007 | CN1960990A Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 05/09/2007 | CN1960981A Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
| 05/09/2007 | CN1960972A Process for forming amorphous atorvastatin calcium |
| 05/09/2007 | CN1960971A Substituted pyrrolidine-2-ones |
| 05/09/2007 | CN1960970A Pyrrolidine derivatives as CB1-receptor antagonists |
| 05/09/2007 | CN1960969A Histamine H3 receptor agents, preparation method and therapeutic uses thereof |
| 05/09/2007 | CN1960965A Synthesis of amino-alkoxy-heptanoic alkyl ester |
| 05/09/2007 | CN1960727A Naphthalene derivatives useful as histamine-3-receptor ligands |
| 05/09/2007 | CN1314656C 9,9-bis(triphenyl amino) fluorine derivatives and preparation and use thereof |
| 05/08/2007 | US7214819 Fluorous triphasic reaction and separation processes for the generation of enantioenriched alcohols, amines, carboxylic acids and related compounds |
| 05/08/2007 | US7214813 Preparation of chiral cyclic amino acids and derivatives |
| 05/08/2007 | US7214804 Heterocyclic compounds useful as growth hormone secretagogues |
| 05/08/2007 | US7214803 Amidation of an alpha-pyrrolidinonylalkanoate by reaction with ammonium hydroxide |
| 05/08/2007 | US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 05/08/2007 | US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases |
| 05/08/2007 | US7214679 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/08/2007 | CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/03/2007 | WO2007050522A1 Derivatives for modulation of ion channels |
| 05/03/2007 | WO2007049736A1 Concentration crystallizer and method |
| 05/03/2007 | WO2007049123A1 Histamine-3 receptor antagonists |
| 05/03/2007 | WO2007048595A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/03/2007 | WO2007048556A1 Heterocyclic amide derivatives useful as microbiocides |
| 05/03/2007 | US20070100150 cost effective way producing Levetiracetam; catalysis the amidation reaction from 5-hydroxy-4-n-propyl-furan-2-one intermediate |
| 05/03/2007 | US20070099983 Aminocyclohexyl ether compounds and uses thereof |
| 05/03/2007 | US20070099922 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide |
| 05/03/2007 | US20070099913 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase IV and methods |
| 05/03/2007 | US20070099897 Therapeutic compounds |
| 05/03/2007 | US20070099826 Treatment of diseases associated with the egr-1 enhancer element |
| 05/03/2007 | CA2627240A1 Alkoxyalkyl spirocyclic tetramic acids and tetronic acids |
| 05/03/2007 | CA2627234A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/03/2007 | CA2626312A1 Heterocyclic amide derivatives useful as microbiocides |
| 05/03/2007 | CA2626190A1 Derivatives for modulation of ion channels |
| 05/02/2007 | EP1780197A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 05/02/2007 | EP1778703A1 Coupling agents comprising a photolabile protecting group and uses thereof, such as for the functionalisation of solid supports |
| 05/02/2007 | EP1778702A2 Antiviral compounds |
| 05/02/2007 | EP1778679A1 Piperazine derivatives useful for the treatment of gastrointestinal disorders |
| 05/02/2007 | EP1778617A1 Process for preparing nitrooxy esters, nitrooxy thioesters, nitrooxy carbonates and nitrooxy thiocarbonates, intermediates useful in said process and preparation thereof |
| 05/02/2007 | EP1482919B1 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes |
| 05/02/2007 | EP1418905B1 Therapeutic agent for depletion of an unwanted protein population from plasma |
| 05/02/2007 | EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 05/02/2007 | EP1322608B1 Delta1-pyrrolines used as pesticides |
| 05/02/2007 | EP1299342B1 Method for producing 3,3-diarylpropylamines |
| 05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 05/02/2007 | CN1956968A Aryl glycinamide derivatives and their use as NK1 antagonists and 5-serotonin reuptake inhibithors |
| 05/02/2007 | CN1956953A Process for the preparation of optically pure 4-hydroxy-2-oxo-1-pyrrolidine acetamide |
| 05/02/2007 | CN1956952A Histamine H3 receptor agents, preparation and therapeutic uses |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/02/2007 | CN1313447C 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 05/02/2007 | CN1313446C Method for the simultaneous production of tetrahydrofurans and pyrrolidones |
| 05/01/2007 | US7211696 Antileishmanial dinitroaniline sulfanomides with activity against parasite tubulin |
| 05/01/2007 | US7211680 (5Z,7E,22E)-(1S,3R,24R)-25-phenyl-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; treating hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS |
| 05/01/2007 | US7211678 Crystal of 2-amino-3-cyano-4-methyl-5-(2-fluorophenyl)pyrrole; treating pollakiuria or urinary incontinence. |
| 05/01/2007 | US7211677 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one |
| 05/01/2007 | US7211666 N-Cyclopropyl-4-[[5-[(methoxyamino)carbonyl]-2-methylphenyl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide; aminating with chloramine to produce a pyrrole with a Nitrogen nitrogen bond; reacting with formamide, cyclizing to form the pyrrolotriazine core; kinase inhibitors |
| 05/01/2007 | US7211653 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
| 05/01/2007 | US7211601 Prevention labor contraction; urogenital disorders |
| 05/01/2007 | US7211394 Providingformulation comprising a nascent protein comprising an affinity marker and a photocleavable detectable label, and ) a surface comprising an acceptor molecule; and interacting affinity marker with acceptor molecule so as to form a protein coated surface |
| 05/01/2007 | CA2308922C Process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine |
| 04/26/2007 | WO2007046554A1 Process for production of dibenzoxepinopyrrole compound, intermediate for production of the compound, and process for production of the intermediate |
| 04/26/2007 | WO2007046201A1 Metal complex, light-emitting material, and light-emitting device |
| 04/26/2007 | WO2007045572A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| 04/26/2007 | WO2007045420A2 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 04/26/2007 | WO2006103696A3 Process for preparing levetiracetam and racemization of (r)- and (s)-2-amino butynamide and the corresponding acid derivatives |
| 04/26/2007 | US20070093529 Diacylhydrazine derivatives |
| 04/26/2007 | US20070093522 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide |
| 04/26/2007 | US20070093492 Pyrrolidine derivatives |
| 04/26/2007 | US20070092540 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof |
| 04/26/2007 | US20070092467 Oxyacetamide compounds useful for stimulating or inducing the growth and/or retarding the loss of keratin fibers |
| 04/26/2007 | CA2829487A1 Organic compounds |
| 04/26/2007 | CA2625918A1 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
| 04/26/2007 | CA2625039A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| 04/26/2007 | CA2625034A1 3-alkyl-5-(4-alkyl-5-oxo-tetrahydrofutran-2-yl)pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 04/26/2007 | CA2624166A1 Inhibitors of viral replication |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1776337A2 Benzyloxy derivatives as maob inhibitors |
| 04/25/2007 | EP1631533A4 Novel process for stereoselective reduction of beta-ketoesters |
| 04/25/2007 | EP1560939A4 Immobilization of biological molecules onto surfaces coated with monolayers |
| 04/25/2007 | EP1084269B1 Novel peroxidase substrates and their use in catalyzed reporter deposition |
| 04/25/2007 | EP1054860B1 Process for the synthesis of 1,3-diols |
| 04/25/2007 | CN1953963A Process for producing cyclic N-hydroxyimide compound |
| 04/25/2007 | CN1953962A A process for the preparation of 2,2-disubstituted pyrroles |
| 04/25/2007 | CN1312153C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 04/25/2007 | CN1312127C 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 04/25/2007 | CN1312116C Calcium acceptor active compound |
| 04/24/2007 | US7208608 Conversion of (3R,5R) 7-[3-phenyl-4-phenylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid or its salt containing alkali metal or ammonium cation, by treatment of the calcium salt to the hemi-calcium salt, followed by precipitation with C5 C12 hydrocarbon or dialkyl ether |
| 04/24/2007 | US7208605 Functionalized ionic liquids, and methods of use thereof |
| 04/24/2007 | US7208602 N-sulfonyl- azetidines, pyrrolidines, piperidines and hexamethylenimines; treatment and prevention of Alzheimer's Disease and other diseases relating to the deposition of amyloid protein. |
| 04/24/2007 | US7208566 Imide-linked maleimide and polymaleimide compounds |
| 04/24/2007 | US7208515 Diphenylmethyl compounds useful as muscarinic receptor antagonists |